We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVRG icon
376
Evergy
EVRG
$20.1B
$8.98M 0.05%
161,774
-48,856
-23% -$2.68M
SPWH icon
377
Sportsman's Warehouse
SPWH
$43.7M
$8.9M 0.05%
507,299
-228,133
-31% -$3.34M
WNS
378
DELISTED
WNS Holdings
WNS
$8.87M 0.05%
123,066
-132,337
-52% -$8.87M
AGCO icon
379
AGCO
AGCO
$8.78B
$8.85M 0.05%
+85,859
New +$7.63M
WHD icon
380
Cactus
WHD
$3.83B
$8.8M 0.05%
337,749
-31,707
-9% -$718K
DPZ icon
381
Domino's
DPZ
$11B
$8.8M 0.05%
22,950
-170,069
-88% -$66.8M
OLLI icon
382
Ollie's Bargain Outlet
OLLI
$4.01B
$8.79M 0.05%
107,522
-1,299
-1% -$114K
YAC
383
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$8.76M 0.05%
+867,340
New +$8.61M
MSCI icon
384
MSCI
MSCI
$40B
$8.74M 0.05%
19,576
-46,053
-70% -$18.1M
COHR icon
385
Coherent
COHR
$55.2B
$8.74M 0.05%
+115,035
New +$6.82M
EEM icon
386
CALL
iShares MSCI Emerging Markets ETF
EEM
$28B
$8.68M 0.05%
168,000
-507,100
-75% -$24.4M
LMT icon
387
Lockheed Martin
LMT
$134B
$8.66M 0.05%
24,389
-37,508
-61% -$13.8M
FELE icon
388
Franklin Electric
FELE
$4.67B
$8.64M 0.05%
124,777
+14,656
+13% +$967K
FHI icon
389
Federated Hermes
FHI
$4.4B
$8.63M 0.05%
298,682
-51,992
-15% -$1.38M
EXR icon
390
Extra Space Storage
EXR
$31.2B
$8.62M 0.05%
+74,432
New +$8.48M
VNO icon
391
Vornado Realty Trust
VNO
$7.47B
$8.61M 0.05%
+230,626
New +$8.42M
O icon
392
Realty Income
O
$61.2B
$8.6M 0.05%
142,828
+72,988
+105% +$4.31M
ATIP
393
DELISTED
ATI Physical Therapy, Inc.
ATIP
$8.58M 0.05%
+16,000
New +$8.07M
IEX icon
394
IDEX
IEX
$16.5B
$8.57M 0.05%
43,017
+40,700
+1,757% +$7.74M
OWL icon
395
Blue Owl Capital
OWL
$6.39B
$8.54M 0.05%
+749,988
New +$8.11M
PSN icon
396
Parsons
PSN
$6.28B
$8.5M 0.05%
233,525
-6,281
-3% -$211K
CSCO icon
397
Cisco
CSCO
$450B
$8.41M 0.05%
187,886
+127,509
+211% +$5.24M
TTC icon
398
Toro Company
TTC
$8.93B
$8.39M 0.05%
88,466
-9,049
-9% -$800K
MCO icon
399
Moody's
MCO
$81.7B
$8.17M 0.04%
28,142
-21,265
-43% -$5.95M
GNW icon
400
Genworth Financial
GNW
$3.8B
$8.15M 0.04%
2,156,706
+486,728
+29% +$2M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.